Skip to main content

FDA Mulls Over Approval Of Controversial Alzheimer's Drug

The FDA is poised to decide whether to approve aducanumab, a drug to treat Alzheimer's. It's proved highly effective at removing the sticky amyloid plaques associated with the disease from the brain.

[Copyright 2021 NPR]

Why you can trust KUOW
Close
On Air Shows

Print

Print

Play Audio
 Live Now On KUOW
KUOW Live Stream
On Air Shows

Print

Print

Play Audio
Local Newscast
The Latest
View All
    Play Audio